Xanax Withdrawal & Tapering Guide
alprazolam
Boxed Warning
Concomitant use with opioids may result in profound sedation, respiratory depression, coma, and death. Risks of abuse, misuse, and addiction, which can lead to overdose and death. Physical dependence and life-threatening withdrawal reactions.
In short
Xanax (alprazolam) is a Benzodiazepine with a half-life of 6–12 hours. Very short half-life makes this the hardest benzodiazepine to taper. Withdrawal symptoms, when they occur, usually begin 6-12 hours after missed dose (fastest of all common benzos) and settle within 2-4 weeks for acute symptoms if tapered properly. It is also sold as Niravam.
- Class
- Benzodiazepine
- Half-life
- 6–12 hours
- Common doses
- 0.25mg, 0.5mg, 1mg, 2mg
- Withdrawal onset
- 6-12 hours after missed dose (fastest of all common benzos)
- Typical resolution
- 2-4 weeks for acute symptoms if tapered properly
Educational reference only. Dose changes are decided with the prescriber who knows your history.
Overview
Alprazolam is a short-acting, high-potency benzodiazepine approved for anxiety disorders and panic disorder. It is the most commonly prescribed benzodiazepine in the US and has the highest abuse potential among benzodiazepines due to rapid onset and short duration.
0.25mg, 0.5mg, 1mg, 2mg
Tablets: 0.25mg, 0.5mg, 1mg, 2mg; Extended-release tablets (XR): 0.5mg, 1mg, 2mg, 3mg; Orally disintegrating tablets: 0.25mg, 0.5mg, 1mg, 2mg; Oral concentrate: 1mg/mL
Category D (positive evidence of risk)
Mechanism of Action
Positive allosteric modulator at GABA-A receptors. Binds to the benzodiazepine site, enhancing GABA-mediated inhibition. Its rapid onset and short half-life contribute to both its anxiolytic efficacy and high dependence liability.
Taper Notes
Very short half-life makes this the hardest benzodiazepine to taper. Inter-dose withdrawal common. Crossover to diazepam strongly recommended.
Hyperbolic Tapering Guidance
Crossover to diazepam essential for safe taper. Very short half-life causes interdose withdrawal. Never stop abruptly.
Summary written by TaperCommunity, informed by the Maudsley Deprescribing Guidelines (Horowitz & Taylor) and related literature — see Sources & References below. Not affiliated with or endorsed by the Maudsley.
Tapering Protocol
Evidence-based phased reduction schedule. Always taper under medical supervision.
| Phase | Duration | Notes |
|---|---|---|
| Crossover to diazepam | 2-4 weeks | Strongly recommended due to Xanax's short half-life. Your prescriber will determine equivalence and crossover schedule. |
| Initial diazepam reductions | 2-4 weeks per step | Once stabilized on diazepam, your prescriber begins gradual reductions. Diazepam's long half-life makes each step smoother. |
| Middle reductions | 3-6 months | Progressively smaller reductions. Liquid diazepam may be used for precision. |
| Final reductions | 3-6 months | Very gradual approach. Work closely with your prescriber through this phase. |
Withdrawal Timeline
6-12 hours after missed dose (fastest of all common benzos)
2-4 days (acute withdrawal can be medically dangerous)
2-4 weeks for acute symptoms if tapered properly
Rebound panic, cognitive impairment, agoraphobia, and depersonalization may persist 6-18 months. Xanax has the highest reported rate of protracted withdrawal among benzos.
Community Tips
Practical insights shared by members tapering Xanax. Not medical advice — always consult your prescriber.
- 1Xanax's short half-life makes direct tapering very challenging. Discuss the diazepam crossover approach (recommended by Ashton and Maudsley) with your prescriber.
- 2If your prescriber recommends direct tapering, ask about XR formulation — it provides a smoother plasma curve than IR.
- 3Rebound panic attacks during Xanax taper are common and can feel indistinguishable from the original anxiety disorder. They are temporary and will resolve.
- 4Never adjust your Xanax dose on your own — always work with your prescriber. Contact them if withdrawal symptoms are unmanageable.
- 5Track your symptoms daily in your taper journal. This data is invaluable for your prescriber in planning pace adjustments.
Common Withdrawal Symptoms
Interactions & Safety
Drug Interactions
- Opioids — FDA boxed warning: concurrent use increases risk of profound sedation, respiratory depression, coma, and death
- CYP3A4 inhibitors (ketoconazole, itraconazole, nefazodone, fluvoxamine) significantly increase alprazolam levels
- CYP3A4 inducers (carbamazepine, rifampin) decrease alprazolam levels
Food Interactions
- Food does not significantly affect absorption
- Avoid alcohol (additive CNS and respiratory depression, potentially fatal)
- Grapefruit juice increases levels via CYP3A4 inhibition
Contraindications
- Acute narrow-angle glaucoma
- Concurrent ketoconazole or itraconazole
- Known hypersensitivity to alprazolam or other benzodiazepines
Toxicity
Severe CNS and respiratory depression (especially with opioids/alcohol). Extremely high physical dependence potential. Withdrawal seizures and death possible with abrupt discontinuation. Rebound anxiety between doses.
Pharmacokinetics
ADME Profile
Rapidly absorbed after oral administration. Bioavailability ~80–90%. Tmax 1–2 hours (IR), ~11 hours (XR). Food does not significantly affect total absorption.
~0.9–1.2 L/kg
Hepatic via CYP3A4 (primary) to alpha-hydroxyalprazolam (weakly active) and a benzophenone derivative (inactive).
Renal (~80% as metabolites). Less than 20% excreted unchanged in urine.
~80%
~1.0–1.3 mL/min/kg
Need a clinician who understands tapering?
Browse our map of deprescribing-informed providers worldwide.
Other Drug Profiles
The arithmetic of a proportional reduction
The Maudsley Deprescribing Guidelines and NICE NG222 describe reducing benzodiazepines and related drugs by a proportion of the previous dose rather than by a fixed amount, so each cut is smaller than the last. The table shows what that arithmetic produces at 10% per step, using 0.5 mg only as a worked example. How large each step is, how long it is held, and whether this pattern applies at all are decisions for the person and their prescriber.
| Step | % of starting dose | Worked example (0.5 mg start) |
|---|---|---|
| Start | 100% | 0.5 mg |
| Step 1 | 90% | 0.45 mg |
| Step 2 | 81% | 0.405 mg |
| Step 3 | 73% | 0.365 mg |
| Step 4 | 66% | 0.328 mg |
| Step 5 | 59% | 0.295 mg |
| Step 6 | 53% | 0.266 mg |
| Step 7 | 48% | 0.239 mg |
| Step 8 | 43% | 0.215 mg |
This is an illustration of a published method, not a schedule for anyone. It does not account for how long you have taken Xanax, your current dose, formulation, or history. TaperCommunity does not recommend doses or dose changes; those are agreed with your prescriber.
Frequently asked questions about Xanax
What are the withdrawal symptoms of Xanax (alprazolam)?
Common withdrawal symptoms of Xanax (alprazolam) include: severe anxiety, insomnia, seizure risk, panic attacks, tremor, depersonalization. Symptom severity varies by individual, dose, and duration of use.
How should I taper off Xanax (alprazolam)?
Very short half-life makes this the hardest benzodiazepine to taper. Inter-dose withdrawal common. Crossover to diazepam strongly recommended. Crossover to diazepam essential for safe taper. Very short half-life causes interdose withdrawal. Never stop abruptly.
How long does Xanax withdrawal last?
Xanax withdrawal typically begins 6-12 hours after missed dose (fastest of all common benzos), peaks around 2-4 days (acute withdrawal can be medically dangerous), and resolves within 2-4 weeks for acute symptoms if tapered properly. Rebound panic, cognitive impairment, agoraphobia, and depersonalization may persist 6-18 months. Xanax has the highest reported rate of protracted withdrawal among benzos.
Can I stop Xanax cold turkey?
Stopping Xanax abruptly is not recommended. Its half-life is 6–12 hours, and the receptor adaptations built up during treatment do not reverse at that speed, so a sudden stop tends to produce the sharpest withdrawal. Prescribing guidance favours gradual, proportional reductions agreed with your prescriber.
How long does Xanax stay in your system?
Xanax (alprazolam) has a half-life of 6–12 hours. A drug is mostly cleared after about five half-lives, so Xanax is largely out of the body roughly 30 hours to 3 days after the last dose, longer in older adults or with liver or kidney impairment. Withdrawal symptoms often begin before the drug has fully cleared and continue after it has, because the adaptations the brain made during treatment reverse more slowly than the drug leaves the blood.
What tips do others have for tapering Xanax?
Xanax's short half-life makes direct tapering very challenging. Discuss the diazepam crossover approach (recommended by Ashton and Maudsley) with your prescriber. If your prescriber recommends direct tapering, ask about XR formulation — it provides a smoother plasma curve than IR. Rebound panic attacks during Xanax taper are common and can feel indistinguishable from the original anxiety disorder. They are temporary and will resolve. Never adjust your Xanax dose on your own — always work with your prescriber. Contact them if withdrawal symptoms are unmanageable.
Recent discussions about Xanax
What members tapering Xanax are asking and reporting right now. Personal experience, not medical advice.
Sources & References
Xanax (alprazolam) information on this page is sourced from peer-reviewed research, regulatory bodies, clinical guidelines, and patient-advocacy organizations.
Encyclopedic & chemical databases
Neutral, high-authority entity references.
Regulatory sources
Official prescribing information and safety notices.
Peer-reviewed research
Primary literature cited in this taper guide.
- Lader M 2014 — Benzodiazepine harm: how can it be reduced? (British Journal of Clinical Pharmacology)
- Ashton CH 2005 — The diagnosis and management of benzodiazepine dependence (Current Opinion in Psychiatry)
- Horowitz MA, Taylor D 2019 — Tapering of SSRI treatment to mitigate withdrawal symptoms (hyperbolic taper) (The Lancet Psychiatry)
Clinical guidelines
Evidence-based deprescribing and prescribing standards.
Deprescribing-specific resources
Clinician-facing references on tapering protocols.
- Ashton Manual (Prof. C. Heather Ashton) — Definitive clinical reference on benzodiazepine taper protocols
- British National Formulary (BNF) — UK formulary guidance on benzodiazepine prescribing
- Deprescribing.org — benzodiazepine algorithm — Evidence-based benzodiazepine deprescribing algorithm
Patient-advocacy & lived-experience
Long-running communities documenting withdrawal experience.
- BenzoBuddies — peer support forum — Largest peer-support community for benzodiazepine taper and withdrawal
- Benzodiazepine Information Coalition — Non-profit education on benzodiazepine dependence and withdrawal
- Inner Compass Initiative — Withdrawal Project — Peer-led psychiatric drug withdrawal resources
- Surviving Antidepressants — benzo & sleep med forum — Community archive of benzodiazepine taper experiences
TaperCommunity does not provide medical advice. Always consult a qualified prescriber before adjusting psychiatric medication.